Matos Joana I, de Sousa Henrique A C, Marcos-Pinto Ricardo, Dinis-Ribeiro Mário
aCIDES, Medical Faculty bInstitute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto cCentro Hospitalar do Porto dPortuguese Institute of Oncology, Porto, Portugal.
Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1431-41. doi: 10.1097/MEG.0b013e328364b53e.
CagA+ and vacuolizing cytotoxin (VacA)-specific strains of Helicobacter pylori have been associated with different risks for developing gastric lesions. We aim to summarize a possible association between these genotypes and the risk for developing different gastric phenotypes.
A MEDLINE database (PubMed) search was performed and a meta-analysis conducted.
Forty-four studies were retrieved, all with either a case-control (n=13) or cross-sectional (n=31) design, including 17 374 patients. CagA positivity was associated with an increased risk for gastric cancer [odds ratio (OR) 2.09 (95% confidence interval (CI), 1.48-2.94)] compared with that in individuals without gastric lesions [OR 2.44 (95% CI 1.27-4.70)] and in those with previously identified gastritis. In addition, there was an increased risk for peptic ulcer disease [OR 1.69 (95% CI 1.12-2.55)]. Individuals harboring the H. pylori strains VacA s1 (vs. s2), m1 (vs. m2), s1m1 (vs. s1m2), and s1m1 (vs. s2m2) had an increased risk for development of cancer [OR of 5.32 (95% CI 2.76-10.26), 2.50 (95% CI 1.67-3.750), 2.58 (95% CI 1.24-5.38), and 4.36 (95% CI 2.08-9.10), respectively]. s1m1 strains (vs. s2m2) were also associated with peptic ulcer disease [OR 2.04 (1.01-4.13)].
Our results indicate that individuals infected with CagA+ H. pylori strains and those infected with VacA s1 and m1 strains have an increased risk for gastric cancer. Cohort studies are welcome to integrate this information in the management of at-risk individuals such as those with precancerous cancer conditions and/or a family history of gastric cancer.
幽门螺杆菌的细胞毒素相关基因A(CagA)阳性和空泡毒素(VacA)特异性菌株与发生胃部病变的不同风险相关。我们旨在总结这些基因型与发生不同胃表型风险之间可能存在的关联。
进行了医学文献数据库(PubMed)检索并开展了一项荟萃分析。
检索到44项研究,均采用病例对照(n = 13)或横断面(n = 31)设计,共纳入17374例患者。与无胃部病变的个体[比值比(OR)2.44(95%置信区间(CI),1.27 - 4.70)]以及先前已确诊胃炎的个体相比,CagA阳性与胃癌风险增加相关[OR 2.09(95% CI,1.48 - 2.94)]。此外,消化性溃疡疾病风险也增加[OR 1.69(95% CI 1.12 - 2.55)]。携带VacA s1(相对于s2)、m1(相对于m2)、s1m1(相对于s1m2)和s1m1(相对于s2m2)幽门螺杆菌菌株的个体患癌风险增加[OR分别为5.32(95% CI 2.76 - 10.26)、2.50(95% CI 1.67 - 3.75)、2.58(95% CI 1.24 - 5.38)和4.36(95% CI 2.08 - 9.10)]。s1m1菌株(相对于s2m2)也与消化性溃疡疾病相关[OR 2.04(1.01 - 4.13)]。
我们的结果表明,感染CagA阳性幽门螺杆菌菌株的个体以及感染VacA s1和m1菌株的个体患胃癌风险增加。欢迎队列研究将这些信息纳入对高危个体(如患有癌前病变和/或有胃癌家族史的个体)的管理中。